Reed Elizabeth E's Form 4 filing
Travere Therapeutics, Inc. (TVTX) · filed Sep 5, 2023
- Accession no.
- 0001209191-23-048256
- Filed
- Sep 5, 2023
- Trade date
- Aug 31-Sep 5, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $26.7K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Reed Elizabeth ECIK 0001283303 | Officer (SVP, GC & Corporate Secretary) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2023 | Common Stock | AGrant or awardAcquired | +3,300 | $0.00 | $0 | 59,911 | Direct | |
| Sep 5, 2023 | Common Stock | SSaleDisposed | −1,815 | $14.71 | −$26,698.65 | 58,096 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.